Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
31 Dec 24 | NVAX Novavax | Common Stock | Grant | Acquire A | No | No | 8.61 | 1,178 | 10.14 k | 15,168 |
30 Sep 24 | NVAX Novavax | Common Stock | Grant | Acquire A | No | No | 12.77 | 778 | 9.94 k | 13,990 |
30 Jun 24 | NVAX Novavax | Common Stock | Grant | Acquire A | No | No | 13.93 | 713 | 9.93 k | 13,212 |
12 Jun 24 | NVAX Novavax | Common Stock | Option exercise | Acquire M | No | No | 0 | 6,670 | 0.00 | 10,470 |
12 Jun 24 | NVAX Novavax | RSU Common Stock | Grant | Acquire A | No | No | 0 | 10,420 | 0.00 | 10,420 |
12 Jun 24 | NVAX Novavax | Stock Option Common Stock | Grant | Acquire A | No | No | 15.86 | 15,630 | 247.89 k | 15,630 |
12 Jun 24 | NVAX Novavax | RSU Common Stock | Option exercise | Dispose M | No | No | 0 | 6,670 | 0.00 | 0 |
6 Jun 24 | FOLD Amicus Therapeutics | Common Stock | Grant | Acquire A | No | No | 0 | 11,847 | 0.00 | 71,136 |
6 Jun 24 | FOLD Amicus Therapeutics | Stock Options Common Stock | Grant | Acquire A | No | No | 10.27 | 42,467 | 436.14 k | 42,467 |
31 Mar 24 | NVAX Novavax | Common Stock | Grant | Acquire A | No | No | 4.9 | 2,029 | 9.94 k | 5,829 |